The Circular RNA circSKA3 Facilitates the Malignant Biological Behaviors of Medulloblastoma via miR-520 h/CDK6 Pathway
- PMID: 35352283
- DOI: 10.1007/s12033-022-00466-4
The Circular RNA circSKA3 Facilitates the Malignant Biological Behaviors of Medulloblastoma via miR-520 h/CDK6 Pathway
Abstract
Circular RNAs (circRNAs) are reported to participate in the development of diverse human malignancies. This work investigated the mechanism of circSKA3 in modulating medulloblastoma progression. A total of 15 cases of medulloblastoma were collected in this work. Daoy cells were used to construct cell models. The expression level of circSKA3, microRNA-520 h (miR-520 h), and cyclin-dependent kinase 6 (CDK6) mRNA in tissues or cells was examined by quantitative real-time polymerase chain reaction (qRT-PCR). Western blot was employed to detect CDK6 protein expression. CCK-8 experiment, Transwell assay, and flow cytometry were applied to detect the regulatory effects of circSKA3 on cell proliferation, migration, invasion, and cell cycle. Dual-luciferase reporter gene experiment was executed to determine the relationship between circSKA3 and miR-520 h, and between miR-520 h and CDK6. circSKA3 was remarkably up-modulated in medulloblastoma tissues. CircSKA3 depletion markedly suppressed Daoy cell viability, migration, invasion, and cell cycle progression. CircSKA3 overexpression induced the opposite effects. circSKA3 could decoyed miR-520 h, which targeted the 3' UTR of CDK6. circSKA3 expression in medulloblastoma tissues was negatively correlated with miR-520 h expression and positively correlated with CDK6 expression. "Rescue" experiments revealed that miR-520 h down-modulation or CDK6 overexpression remarkably counteracted the inhibitory effect of circSKA3 knockdown on Daoy cells. circSKA3 facilitates medulloblastoma progression through miR-520 h/CDK6.
Keywords: CDK6; Medulloblastoma; circSKA3; miR-520 h.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Circ_SEC61A1 contributes to the progression of multiple myeloma cells via regulating miR-660-5p/CDK6 axis.Leuk Res. 2022 Feb;113:106774. doi: 10.1016/j.leukres.2021.106774. Epub 2021 Dec 31. Leuk Res. 2022. PMID: 35030455
-
Triptolide inhibits the proliferation and migration of medulloblastoma Daoy cells by upregulation of microRNA-138.J Cell Biochem. 2018 Dec;119(12):9866-9877. doi: 10.1002/jcb.27307. Epub 2018 Aug 28. J Cell Biochem. 2018. Retraction in: J Cell Biochem. 2021 Nov;122 Suppl 1:S24. doi: 10.1002/jcb.29983. PMID: 30156009 Retracted.
-
CircSKA3 Modulates FOXM1 to Facilitate Cell Proliferation, Migration, and Invasion While Confine Apoptosis in Medulloblastoma via miR-383-5p.Cancer Manag Res. 2020 Dec 30;12:13415-13426. doi: 10.2147/CMAR.S272753. eCollection 2020. Cancer Manag Res. 2020. PMID: 33408514 Free PMC article.
-
Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p.J Cell Physiol. 2019 Apr;234(4):4812-4824. doi: 10.1002/jcp.27280. Epub 2018 Oct 26. J Cell Physiol. 2019. PMID: 30362519
-
Role of Circular RNA in Brain Tumor Development.Cells. 2022 Jul 6;11(14):2130. doi: 10.3390/cells11142130. Cells. 2022. PMID: 35883576 Free PMC article. Review.
Cited by
-
Circular RNAs: the next level of gene regulation.Am J Transl Res. 2023 Oct 15;15(10):6122-6135. eCollection 2023. Am J Transl Res. 2023. PMID: 37969203 Free PMC article.
-
The Role of the Dysregulation of Long Non-Coding and Circular RNA Expression in Medulloblastoma: A Systematic Review.Cancers (Basel). 2023 Sep 22;15(19):4686. doi: 10.3390/cancers15194686. Cancers (Basel). 2023. PMID: 37835380 Free PMC article. Review.
-
Plasma Circular RNAs as Biomarkers for Breast Cancer.Biomedicines. 2024 Apr 16;12(4):875. doi: 10.3390/biomedicines12040875. Biomedicines. 2024. PMID: 38672229 Free PMC article. Review.
-
An Update on Circular RNA in Pediatric Cancers.Biomedicines. 2022 Dec 23;11(1):36. doi: 10.3390/biomedicines11010036. Biomedicines. 2022. PMID: 36672544 Free PMC article. Review.
-
CircRNA and lncRNA-associated competing endogenous RNA networks in medulloblastoma: a scoping review.Cancer Cell Int. 2024 Jul 15;24(1):248. doi: 10.1186/s12935-024-03427-w. Cancer Cell Int. 2024. PMID: 39010056 Free PMC article.
References
-
- Udaka, Y. T., & Packer, R. J. (2018). Pediatric brain tumors. Neurologic Clinics, 36(3), 533–556. - DOI
-
- Gupta, A., & Dwivedi, T. (2017). A simplified overview of world health organization classification update of central nervous system tumors 2016. J Neurosci Rural Pract, 8(4), 629–641. - DOI
-
- Gupta, T., Jalali, R., Goswami, S., Nair, V., Moiyadi, A., Epari, S., & Sarin, R. (2012). Early clinical outcomes demonstrate preserved cognitive function in children with average-risk medulloblastoma when treated with hyperfractionated radiation therapy. Int J Radiat Oncol Biol Phys, 83(5), 1534–1540. - DOI
-
- Gajjar, A. J., & Robinson, G. W. (2014). Medulloblastoma-translating discoveries from the bench to the bedside. Nat Rev Clin Oncol, 11(12), 714–722. - DOI
-
- Ashwal-Fluss, R., Meyer, M., Pamudurti, N. R., Ivanov, A., Bartok, O., Hanan, M., Evantal, N., Memczak, S., Rajewsky, N., & Kadener, S. (2014). circRNA biogenesis competes with pre-mRNA splicing. Mol Cell, 56(1), 55–66. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources